PULMATRIX, INC. Deferred Costs, Current
PULMATRIX, INC. (PULM) had Deferred Costs, Current of $283.00 thousand as of 2021-06-30, per its 10-Q filed 2021-08-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Deferred Costs, Current
us-gaap:DeferredCostsCurrent · last filed 2021-11-10
- 2021-06-30: Deferred Costs, Current $283.00K.
- 2021-03-31: Deferred Costs, Current $66.00K.
- 2020-12-31: Deferred Costs, Current $74.00K.
- 2020-09-30: Deferred Costs, Current $31.00K.
| Period end | Deferred Costs, Current |
|---|---|
| 2021-06-30 | $283.00K 10-Q · filed 2021-08-10 |
| 2021-03-31 | $66.00K 10-Q · filed 2021-05-11 |
| 2020-12-31 | $74.00K 10-Q · filed 2021-11-10 |
| 2020-09-30 | $31.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $37.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $50.00K 10-Q · filed 2020-05-14 |
| 2019-12-31 | $32.00K 10-K · filed 2021-03-23 |
| 2019-09-30 | $107.00K 10-Q · filed 2019-11-01 |
| 2019-06-30 | $13.00K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $333.00K 10-Q · filed 2019-05-15 |
| 2018-12-31 | $28.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $449.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $101.00K 10-Q · filed 2018-08-03 |
| 2018-03-31 | $98.00K 10-Q · filed 2018-05-11 |
| 2017-12-31 | $27.00K 10-K · filed 2019-02-19 |
| 2017-09-30 | $390.00K 10-Q · filed 2017-11-09 |
| 2017-03-31 | $6.00K 10-Q · filed 2017-05-05 |
| 2016-12-31 | $107.00K 10-K · filed 2018-03-13 |
| 2015-12-31 | $598.00K 10-K · filed 2017-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |